Cardinal Capital Management Inc (North Carolina)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.37M | Buy |
8,316
+280
| +3% | +$147K | 0.64% | 52 |
|
|
2025
Q1 | $5.1M | Buy |
8,036
+165
| +2% | +$105K | 0.79% | 43 |
|
|
2024
Q4 | $5.61M | Buy |
7,871
+36
| +0.5% | +$25.6K | 0.88% | 39 |
|
|
2024
Q3 | $8.24M | Buy |
7,835
+45
| +0.6% | +$47.3K | 1.28% | 25 |
|
|
2024
Q2 | $8.19M | Buy |
7,790
+16
| +0.2% | +$16.8K | 1.38% | 23 |
|
|
2024
Q1 | $7.48M | Buy |
7,774
+284
| +4% | +$273K | 1.22% | 27 |
|
|
2023
Q4 | $6.58M | Sell |
7,490
-16
| -0.2% | -$14.1K | 1.25% | 32 |
|
|
2023
Q3 | $6.18M | Buy |
7,506
+88
| +1% | +$72.4K | 1.26% | 27 |
|
|
2023
Q2 | $5.33M | Buy |
7,418
+57
| +0.8% | +$41K | 1.07% | 36 |
|
|
2023
Q1 | $6.05M | Sell |
7,361
-55
| -0.7% | -$45.2K | 1.25% | 30 |
|
|
2022
Q4 | $5.35M | Sell |
7,416
-46
| -0.6% | -$33.2K | 1.14% | 32 |
|
|
2022
Q3 | $5.14M | Buy |
7,462
+68
| +0.9% | +$46.8K | 1.22% | 28 |
|
|
2022
Q2 | $4.37M | Buy |
7,394
+30
| +0.4% | +$17.7K | 1% | 41 |
|
|
2022
Q1 | $5.14M | Buy |
7,364
+130
| +2% | +$90.8K | 1.04% | 35 |
|
|
2021
Q4 | $4.57M | Sell |
7,234
-22
| -0.3% | -$13.9K | 0.9% | 41 |
|
|
2021
Q3 | $4.39M | Sell |
7,256
-83
| -1% | -$50.2K | 0.95% | 39 |
|
|
2021
Q2 | $4.1M | Sell |
7,339
-25
| -0.3% | -$14K | 0.87% | 42 |
|
|
2021
Q1 | $3.48M | Buy |
7,364
+96
| +1% | +$45.4K | 0.77% | 44 |
|
|
2020
Q4 | $3.51M | Buy |
7,268
+66
| +0.9% | +$31.9K | 0.83% | 45 |
|
|
2020
Q3 | $4.03M | Sell |
7,202
-7
| -0.1% | -$3.92K | 1.11% | 35 |
|
|
2020
Q2 | $4.5M | Sell |
7,209
-29
| -0.4% | -$18.1K | 1.29% | 31 |
|
|
2020
Q1 | $3.53M | Buy |
7,238
+299
| +4% | +$146K | 1.17% | 38 |
|
|
2019
Q4 | $2.61M | Buy |
+6,939
| New | +$2.61M | 0.68% | 49 |
|